Cargando…

A ‘Real Life’ Service Evaluation Model for Multidisciplinary Thyroid Eye Services

BACKGROUND/AIMS: There is no universal consensus on the practical implementation and evaluation of the Amsterdam Declaration on Graves Orbitopathy in a Multidisciplinary Thyroid Eye Disease (MDTED) pathway. Recent recommendations from the UK TEAMeD-5 and BOPSS initiative highlight the importance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Farag, Soma, Feeney, Claire, Lee, Vickie, Nagendran, Sonali, Jain, Rajni, Aziz, Ahmad, Akishar, Rashmi, Bravis, Vassiliki, Meeran, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138583/
https://www.ncbi.nlm.nih.gov/pubmed/34025584
http://dx.doi.org/10.3389/fendo.2021.669871
_version_ 1783695839728762880
author Farag, Soma
Feeney, Claire
Lee, Vickie
Nagendran, Sonali
Jain, Rajni
Aziz, Ahmad
Akishar, Rashmi
Bravis, Vassiliki
Meeran, Karim
author_facet Farag, Soma
Feeney, Claire
Lee, Vickie
Nagendran, Sonali
Jain, Rajni
Aziz, Ahmad
Akishar, Rashmi
Bravis, Vassiliki
Meeran, Karim
author_sort Farag, Soma
collection PubMed
description BACKGROUND/AIMS: There is no universal consensus on the practical implementation and evaluation of the Amsterdam Declaration on Graves Orbitopathy in a Multidisciplinary Thyroid Eye Disease (MDTED) pathway. Recent recommendations from the UK TEAMeD-5 and BOPSS initiative highlight the importance of prevention, screening, and prompt referral of patients with moderate to severe and sight-threatening thyroid eye disease to multidisciplinary (MDTED) clinics and recommends annual auditing. We propose a practical service evaluation model with Key Performance Indicators (KPI) that are achievable and could be implemented across most TED pathways. MATERIAL AND METHODS: We conducted a service evaluation from an integrated TED pathway in London with three MDTED clinics. Data was collected retrospectively from consecutive TED patients included: 1) Patient demographics, 2) Referral to first appointment time, 3) Documented smoking cessation and selenium supplementation advice, 4) Presenting disease activity and severity, 5) Investigations and treatments, including radio-iodine, 6) Time from decision to treatment initiation, 7) Initial and subsequent thyroid status. RESULTS: The median age was 49.0 yrs, 77.5% (183/236) were female and 49.5% (101/204) Afro-Caribbean or Asian. At their first clinic attendance, 47.6% (110/231) were biochemically euthyroid and 76.7% (79/103) at discharge. All 23.1% (52/225) current smokers received smoking cessation advice and 64.8% (153/236) received selenium supplementation advice. Intravenous methylprednisolone was given to 33.9% (80/236) patients and 12.7% (30/236) received second-line immunosuppression. All 7.2% (17/236) patients with sight-threatening disease received treatment within two weeks of diagnosis. CONCLUSIONS: This study forms a waymark for other units using TEAMeD-5 and BOPSS audit criteria. Dedicated electronic patient records with ongoing data capture, including quality of life assessments, and diagnostic coding would significantly aid future auditing, improve patient care, and facilitate a national audit of TED management. A future survey when the TED standards have become embedded would be instructive to see whether this has improved TED care.
format Online
Article
Text
id pubmed-8138583
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81385832021-05-22 A ‘Real Life’ Service Evaluation Model for Multidisciplinary Thyroid Eye Services Farag, Soma Feeney, Claire Lee, Vickie Nagendran, Sonali Jain, Rajni Aziz, Ahmad Akishar, Rashmi Bravis, Vassiliki Meeran, Karim Front Endocrinol (Lausanne) Endocrinology BACKGROUND/AIMS: There is no universal consensus on the practical implementation and evaluation of the Amsterdam Declaration on Graves Orbitopathy in a Multidisciplinary Thyroid Eye Disease (MDTED) pathway. Recent recommendations from the UK TEAMeD-5 and BOPSS initiative highlight the importance of prevention, screening, and prompt referral of patients with moderate to severe and sight-threatening thyroid eye disease to multidisciplinary (MDTED) clinics and recommends annual auditing. We propose a practical service evaluation model with Key Performance Indicators (KPI) that are achievable and could be implemented across most TED pathways. MATERIAL AND METHODS: We conducted a service evaluation from an integrated TED pathway in London with three MDTED clinics. Data was collected retrospectively from consecutive TED patients included: 1) Patient demographics, 2) Referral to first appointment time, 3) Documented smoking cessation and selenium supplementation advice, 4) Presenting disease activity and severity, 5) Investigations and treatments, including radio-iodine, 6) Time from decision to treatment initiation, 7) Initial and subsequent thyroid status. RESULTS: The median age was 49.0 yrs, 77.5% (183/236) were female and 49.5% (101/204) Afro-Caribbean or Asian. At their first clinic attendance, 47.6% (110/231) were biochemically euthyroid and 76.7% (79/103) at discharge. All 23.1% (52/225) current smokers received smoking cessation advice and 64.8% (153/236) received selenium supplementation advice. Intravenous methylprednisolone was given to 33.9% (80/236) patients and 12.7% (30/236) received second-line immunosuppression. All 7.2% (17/236) patients with sight-threatening disease received treatment within two weeks of diagnosis. CONCLUSIONS: This study forms a waymark for other units using TEAMeD-5 and BOPSS audit criteria. Dedicated electronic patient records with ongoing data capture, including quality of life assessments, and diagnostic coding would significantly aid future auditing, improve patient care, and facilitate a national audit of TED management. A future survey when the TED standards have become embedded would be instructive to see whether this has improved TED care. Frontiers Media S.A. 2021-05-07 /pmc/articles/PMC8138583/ /pubmed/34025584 http://dx.doi.org/10.3389/fendo.2021.669871 Text en Copyright © 2021 Farag, Feeney, Lee, Nagendran, Jain, Aziz, Akishar, Bravis and Meeran https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Farag, Soma
Feeney, Claire
Lee, Vickie
Nagendran, Sonali
Jain, Rajni
Aziz, Ahmad
Akishar, Rashmi
Bravis, Vassiliki
Meeran, Karim
A ‘Real Life’ Service Evaluation Model for Multidisciplinary Thyroid Eye Services
title A ‘Real Life’ Service Evaluation Model for Multidisciplinary Thyroid Eye Services
title_full A ‘Real Life’ Service Evaluation Model for Multidisciplinary Thyroid Eye Services
title_fullStr A ‘Real Life’ Service Evaluation Model for Multidisciplinary Thyroid Eye Services
title_full_unstemmed A ‘Real Life’ Service Evaluation Model for Multidisciplinary Thyroid Eye Services
title_short A ‘Real Life’ Service Evaluation Model for Multidisciplinary Thyroid Eye Services
title_sort ‘real life’ service evaluation model for multidisciplinary thyroid eye services
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138583/
https://www.ncbi.nlm.nih.gov/pubmed/34025584
http://dx.doi.org/10.3389/fendo.2021.669871
work_keys_str_mv AT faragsoma areallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT feeneyclaire areallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT leevickie areallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT nagendransonali areallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT jainrajni areallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT azizahmad areallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT akisharrashmi areallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT bravisvassiliki areallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT meerankarim areallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT faragsoma reallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT feeneyclaire reallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT leevickie reallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT nagendransonali reallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT jainrajni reallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT azizahmad reallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT akisharrashmi reallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT bravisvassiliki reallifeserviceevaluationmodelformultidisciplinarythyroideyeservices
AT meerankarim reallifeserviceevaluationmodelformultidisciplinarythyroideyeservices